Skip to content

The annual Brainstorming for Parkinson’s Disease (BSPD) meeting

We are proud to have sponsored the annual Brainstorming for Parkinson’s Disease (BSPD) meeting, where we also presented our latest updates.

This year the meeting was held in Zichron Yaakov, Israel. Speakers included Prof. Daniel Offen, Prof. Izhar Bar-Gad, Prof. Ehud Gazit, Prof. Roy Alcalay, Prof. Avi Orr-Urtreger, Prof. Chuck Adler, Prof. Uri Ashery, and Prof. Amos Korczyn.

Industry representatives, clinicians, academics, and patient advocates all contributed to the collaborative atmosphere. We all shared the common goal of advancing the field of Parkinson’s for the benefit of the millions of people living and struggling with the disease around the world.

More Information

#

Mitsubishi Tanabe Pharma Corporation Provides U.S. Regulatory Update on ND0612

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (hereinafter "CRL") for the New Drug Application (NDA) of investigational ND0612
#

NeuroDerm Announces Publication of Positive Results from Phase 3 BouNDless Trial in "The Lancet Neurology Journal"

Data published in The Lancet Neurology showed favorable efficacy of ND0612 compared to oral immediate-release levodopa/carbidopa
#

World Parkinson’s Day (WPD) - April 11th 2023

The first World Parkinson's Day (WPD) was held in 1997. The date commemorates the birthday of Dr James Parkinson, born 11 April 1755,
More
decoration

Let's Stay in Touch

For general inquiries or to learn more about NeuroDerm, please complete the form below. For medical information or to report on your own health or experience, please consult your healthcare provider. Please click here for information about our clinical trials.

*
*
*
*